CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-01 | Malamut Richard EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Purchase) | +85,000 | 85,000 | ||
| 2019-03-15 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −1,470 | $16.98 | $25K | 44,130 |
| 2019-03-15 | Heffernan Michael Thomas Director | Sale | −25,000 | $17.17 | $429K | 227,362 |
| 2019-02-15 | Heffernan Michael Thomas Director | Sale | −17,932 | $14.71 | $264K | 259,430 |
| 2019-02-15 | Heffernan Michael Thomas Director | Sale | −7,068 | $15.06 | $106K | 252,362 |
| 2019-02-08 | Heffernan Michael Thomas Director | Shares withheld for taxes | −7,851 | $14.39 | $113K | 277,362 |
| 2019-02-08 | Fleming Alison B Chief Technology Officer | Shares withheld for taxes | −2,714 | $14.39 | $39K | 75,254 |
| 2019-02-08 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −2,052 | $14.39 | $30K | 196,606 |
| 2019-02-08 | Brannelly Paul Executive Vice President & CFO | Shares withheld for taxes | −2,693 | $14.39 | $39K | 152,288 |
| 2019-01-25 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +25,600 | 41,786 | ||
| 2019-01-25 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award · Stock Option (Right to Purchase) | +25,600 | 25,600 | ||
| 2019-01-25 | Fleming Alison B Chief Technology Officer | Grant or award | +25,600 | 77,968 | ||
| 2019-01-25 | Fleming Alison B Chief Technology Officer | Grant or award · Stock Option (Right to Purchase) | +25,600 | 25,600 | ||
| 2019-01-25 | Brannelly Paul Executive Vice President & CFO | Grant or award | +32,000 | 154,981 | ||
| 2019-01-25 | Brannelly Paul Executive Vice President & CFO | Grant or award · Stock Option (Right to Purchase) | +32,000 | 32,000 | ||
| 2019-01-25 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +25,600 | 45,600 | ||
| 2019-01-25 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award · Stock Option (Right to Purchase) | +25,600 | 25,600 | ||
| 2019-01-25 | Ciaffoni Joseph President and CEO | Grant or award | +90,000 | 198,658 | ||
| 2019-01-25 | Ciaffoni Joseph President and CEO | Grant or award · Stock Option (Right to Purchase) | +90,000 | 90,000 | ||
| 2019-01-18 | Fleming Alison B Chief Technology Officer | Shares withheld for taxes | −214 | $15.76 | $3K | 52,368 |
Page 28 of 32 · 635 trades